1 |
Heo J(許浚). Donguibogam(東醫寶鑑). Seoul:Bubin-munhwasa. 2012:764-6.
|
2 |
Sethi G, Sung BK, Aggarwal BB.TNF: a master switch for inflammation to cancer.Front Biosci.2008;13(13):5094-201.
DOI
|
3 |
Vaux DL, Gerl R.Apoptosis in the development and treatment of cancer. Carcinogenesis.2005;26(2):263-333.
DOI
|
4 |
Park JG, Bang YJ, Ha SW. Oncology. Rev. ed. Seoul:Ilchokak. 2012:596-7, 606-44.
|
5 |
Song JY, et al.Screening of Antineoplastic Immunomodulator from Herbal Medicines. Yakhak Hoeji.1998;42(2):132-9.
|
6 |
Jo HI.A general perspective on breast disease and training system for breast cancer specialists in Europe.Obstet Gynecol Sci.2010;53(7):565-78.
|
7 |
Kayl AE, Meyers CA.Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Gynecol Obstet.2006;18(1) :24-8.
DOI
|
8 |
Oh HN, et al.Anticancer Effect of Paedoksans for Oral Squamous Cell Carcinoma and Malignant Pleural Mesothelioma.Saengyak Hakhoe Chi. 2017;48(3):213-8.
|
9 |
Shin JY. (申載鏞). Bangyakhappyeonhaeseol (方藥合編解說). Seoul:Shingwang-munhwasa. 1993:178-9.
|
10 |
Jeoung YH, Chae BY.Studies on Effects of Sipyukmiyuki-eum on the Hyperthyroidism.The Journal of K.O.M.S.1988;9(2):98-108.
|
11 |
Greten FR, Grivennikov SI.Inflammation and Cancer: Triggers, Mechanisms, and Consequences.Immunity.2019;51(1) :27-41.
DOI
|
12 |
Perillo B, et al.ROS in cancer therapy: the bright side of the moon.Exp Mol Med.2020;52(2):192-203.
DOI
|
13 |
Hassan M, et al.Apoptosis and molecular targeting therapy in cancer.Biomed Res Int.2014;2014:1-23.
|
14 |
Zimmermann KC, Bonzon C, Green DR.The machinery of programmed cell death.Pharmacol Ther.2001; 92(1):57-70.
|
15 |
Wiseman H, Halliwell B.Damage to DNA by Reactive Oxygen and Nitrogen Species: Role in Inflammatory Disease and Progression to Cancer.Biochem. J.1996;313:17-29.
DOI
|
16 |
Lee TB, Jub JH.Can Hinokitiol Kill Cancer Cells? Alternative Therapeutic Anticancer Agent via Autophagy and Apoptosis.Korean J Clin Lab Sci. 2019;51(2):221-34.
DOI
|
17 |
Noh OK, et al.Probabilities of Pulmonary and Cardiac Complications and Radiographic Parameters in Breast Cancer Radiotherapy. Radiat Oncol J.2010;28(1):23-31
|
18 |
Smoot B, Wampler M, Topp KS.Breast Cancer Treatments and Complications: Implications for Rehabilitation.Phys Ther J Policy Adm Leadersh.2009;27(3) :16-26.
|
19 |
Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer.Oncol Nurs Forum.2001;28(3) :465-70.
|
20 |
Cho SS, et al.Anticancer Activity and Chemical Composition of a Non-Polar Fraction from Asiasari Radix et Rhizoma.Saengyak Hakhoe Chi.2020;51(4):264-9.
|
21 |
Nam KY, et al.Recent Progress in Research on Anticancer Activities of Ginsenoside-Rg3.Saengyak Hakhoe Chi.2014;45(1):1-10.
|
22 |
Han DS, et al.Development of Anticancer Agents from Korean Medicinal Plants (Part 10).The Growth-inhibitory Effect of Taraxaci Herba Extract Against Human Skin Melamoma Cells. J.Toxicol.Pub.Health.1998;14(4) :489-94.
|
23 |
The Society of Korean Medicine Obstetrics & Gynecology. Korean Medicine Obstetrics and Gynecology (Vol 2). 4th rev. ed. Seoul:Euiseongdang. 2021:459, 466-7.
|
24 |
Seo BI, Kim MJ.A clinical study on a patient with postpartum depression and acute mastitis.Kor.J.Herbology. 2003;18(1):145-8.
|
25 |
Lowe SW, Lin AW.Apoptosis in Cancer. Carcinogenesis.2000;21(3):485-95.
DOI
|
26 |
Yi JE, Kim BW.Effects of Sipyukmiyukieum on DNA Synthesis, cAMP Synthesis and MHC-class II Expression of FRTL-5 Thyroid Cells.Korean J. Orient.Int.Med.2005;26(2):398-408.
|
27 |
Jung YC, Park YS, Kim DC.Shipyeukmiyeugieum Extracts Suppressed Tumor Growth through Immunomodulatory Effects on MCF-7.The Journal of Oriental Obstetrics & Gynecology.2012; 25(3):40-60.
|
28 |
Allavena P, et al.Pathways connecting inflammation and cancer.Curr Opin Genet Dev.2008;18(1):3-10.
DOI
|
29 |
Hanahan D, Weinberg RA.Hallmarks of Cancer: the Next Generation.Cell. 2011;144(5):646-74.
DOI
|
30 |
Kapuscinski J.DAPI: a DNA-Specific Fluorescent Probe.Biotech Histochem. 1995;70(5):220-33.
DOI
|
31 |
Doonan F, Cotter TG.Morphological assessment of apoptosis.Methods. 2008;44(3):200-4.
DOI
|
32 |
Renault TT, Dejean LM, Manon S.A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2. Mech Ageing Dev.2017;161:201-10.
DOI
|
33 |
Loboda A, et al.Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.Cell Mol Life Sci.2016;73(17):3221-47.
DOI
|
34 |
Wong PK, et al.Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.Carcinogenesis. 2008;29(6):1235-43.
DOI
|
35 |
Budd RC.Death receptors couple to both cell proliferation and apoptosis. J Clin Invest.2002;109(4):437-78.
DOI
|
36 |
Boulares AH, et al.Role of Poly (ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis.J Biol Chem. 1999;274(33):22932-40.
DOI
|
37 |
Guo YQ, et al.Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev.2012;38(7):904-10.
DOI
|
38 |
Multhoff G, Molls M, Radons J.Chronic inflammation in cancer development. Front Immunol.2011;2:1-17.
DOI
|
39 |
Shrihari TG.Inflammation Related Cancer - Highlights.J Carcinog Mutagen. 2016;7(3):2157-8.
|
40 |
Chiarugi V, Magnelli L, Gallo O.Cox-2, iNOS and p53 as play-makers of tumor angiogenesis.Int J Mol Med. 1998;2(6):715-24.
|
41 |
Sung HA, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA: CA Cancer J Clin.2021;71(3):209-49.
DOI
|
42 |
Korea Central Cancer Registry. National Cancer Center. Annual report of cancer statistics in Korea in 2018. Ministry of Health and Welfare. 2020:22.
|
43 |
Laird BJ, et al.The Emerging Role of Interleukin 1β (IL-1β) in Cancer Cachexia.Inflammation.2021;44(4) :1223-8.
DOI
|